ImmunityBio
IBRX
9.75
+0.06
+0.62%
ImmunityBio
US · IBRX
#1397 by market cap
Listed 1970
9.75
+0.06
+0.62%
Live - 5344 symbols - heartbeat 269s ago
· 2026-10-08 07:00
Pre-market
9.72
-0.28%
After-hours
9.77
+0.16%
Overnight
9.70
-0.51%
- Market cap
- 10.33B
- P/E (TTM)i
- -10.26
- P/Bi
- -9.87
- EPSi
- -0.38
- Div yieldi
- 0.00%
- 52W posi
- 74%
Reader sentiment
Are you bullish or bearish on IBRX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 53.00% -0.32pp
- Institutions
- 443 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Individual/Insider27.90%
VC/PE Fund24.44%
Mutual Fund13.85%
Private Company9.56%
Hedge Fund3.65%
Public Company1.21%
Government Pension Fund0.12%
Family Office/Trust0.11%
Other19.11%
Top holders as of 2026-07-31
Patrick Soon-Shiong
27.50% · 291.46M sh
California Capital Equity, LLC
24.44% · 259.00M sh
NantWorks, LLC
9.30% · 98.54M sh
BlackRock
3.22% · 34.08M sh
State Street Global Advisors
2.02% · 21.40M sh
Vanguard Capital Management, LLC
1.71% · 18.10M sh
Vanguard Portfolio Management, LLC
1.69% · 17.86M sh
D. E. Shaw & Co., L.P.
1.09% · 11.55M sh
Two Sigma Investments, LP
1.05% · 11.10M sh
Geode Capital Management, LLC
0.93% · 9.85M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Patrick Soon-Shiong | Executive Chairman of the Board, Global Chief Scientific & Medical Officer | 27.50% |
| California Capital Equity, LLC | -- | 24.44% |
| Barry Simon | Chief Corporate Affairs Officer & Director | 0.26% |
| Richard Adcock | Chief Executive Officer | 0.05% |
| David Sachs | CFO, Principal Financial Officer & Principal Accounting Officer | 0.03% |
| Michael Blaszyk | Independent Director | 0.03% |
| Cheryl Cohen | Lead Independent Director | 0.01% |
| Regan Lauer | Chief Accounting Officer | 0.01% |
| John Brennan | Independent Director | 0.00% |
| Wesley Clark | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Barry Simon | Chief Corporate Affairs Officer & Director | Intent to Sell (Form 144) | -560,000 | $13.67 |
| 2026-07-01 | Cheryl Cohen | Lead Independent Director | Automatic Disposition | -75,231 | $9.50 |
| 2026-07-01 | Cheryl Cohen | Lead Independent Director | Derivative Exercise and Sale | -55,979 | $2.98–9.50 |
| 2026-06-30 | Christobel Selecky | Independent Director | Derivative Exercise and Sale | -159,478 | $2.98–9.02 |
| 2026-06-29 | Christobel Selecky | Independent Director | Derivative Exercise and Sale | -96,722 | $2.84–9.01 |
| 2026-06-29 | Christobel Selecky | Independent Director | Intent to Sell (Form 144) | -1,000 | $8.77 |
| 2026-06-28 | Christobel Selecky | Independent Director | Intent to Sell (Form 144) | -95,722 | $8.71 |
| 2026-06-23 | Barry Simon | Chief Corporate Affairs Officer & Director | Automatic Disposition | -25,000 | $7.88 |
| 2026-06-08 | Christobel Selecky | Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-08 | Wesley Clark | Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-08 | Bruce Wendel | Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-08 | Michael Blaszyk | Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-08 | Cheryl Cohen | Lead Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-08 | Linda Maxwell | Independent Director | Other Derivative Acquisition | +65,600 | $7.25 |
| 2026-06-03 | Barry Simon | Chief Corporate Affairs Officer & Director | Automatic Disposition | -23,033 | $7.18 |
| 2026-03-30 | California Capital Equity, LLC | -- | Derivative Exercise and Retained | +4,606,596 | $5.43 |
| 2026-02-23 | Barry Simon | Chief Corporate Affairs Officer & Director | Automatic Disposition | -75,000 | $12.01 |
| 2026-02-22 | Christobel Selecky | Independent Director | Derivative Exercise and Sale | -25,000 | $2.98–10.00 |
| 2026-02-22 | Barry Simon | Chief Corporate Affairs Officer & Director | Automatic Disposition | -165,783 | $9.25–10.25 |
| 2026-02-22 | Barry Simon | Chief Corporate Affairs Officer & Director | Derivative Exercise and Sale | -15,243 | $8.70–10.25 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.